NEW YORK STATE COMMON RETIREMENT FUND - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q1 2022$372,000
+24.8%
5,934
+50.8%
0.00%
Q4 2021$298,000
-29.7%
3,934
+4.0%
0.00%
Q3 2021$424,000
-30.8%
3,7840.0%0.00%
-100.0%
Q2 2021$613,000
+4.1%
3,784
-21.7%
0.00%0.0%
Q1 2021$589,000
-51.0%
4,834
-38.4%
0.00%0.0%
Q4 2020$1,201,000
+445.9%
7,844
+197.8%
0.00%
Q3 2020$220,000
+13.4%
2,6340.0%0.00%
Q2 2020$194,000
+73.2%
2,6340.0%0.00%
Q1 2020$112,000
-67.4%
2,634
-53.3%
0.00%
Q4 2019$344,000
+224.5%
5,645
+118.5%
0.00%
Q3 2019$106,000
+5.0%
2,584
+21.1%
0.00%
Q2 2019$101,000
+21.7%
2,134
-8.6%
0.00%
Q1 2019$83,000
+16.9%
2,334
-6.0%
0.00%
Q4 2018$71,000
-77.5%
2,484
-65.0%
0.00%
Q3 2018$315,000
-44.1%
7,103
-25.9%
0.00%
-100.0%
Q2 2018$564,000
+27.3%
9,591
-1.0%
0.00%0.0%
Q1 2018$443,000
+119.3%
9,691
+12.9%
0.00%
Q4 2017$202,000
-41.3%
8,584
-55.5%
0.00%
Q3 2017$344,00019,2760.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$32,581,00055.55%
NEA Management Company, LLC 1,590,002$103,907,0005.19%
ARK Investment Management 8,237,122$538,296,0003.75%
Nikko Asset Management Americas, Inc. 4,262,736$277,078,0003.54%
CLOUGH CAPITAL PARTNERS L P 414,767$27,105,0002.89%
Integral Health Asset Management, LLC 220,000$14,377,0002.79%
PLUSTICK MANAGEMENT LLC 50,000$3,268,0002.48%
HC Advisors, LLC 53,944$3,525,0002.43%
Green Alpha Advisors, LLC 27,466$1,795,0001.52%
EFG Asset Management (North America) Corp. 84,356$5,516,0001.28%
View complete list of CRISPR THERAPEUTICS AG shareholders